Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (101-110 of 318) with videos related to

Pageof 32
Sort By:
Nature Medicine|June 12, 2025
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Nature Medicine|March 9, 2023
Challenges and opportunities in NASH drug developmentStephen A Harrison, Alina M Allen, Julie Dubourg, et al.
Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2010
MiraLAX is not as effective as GoLytely in bowel cleansing before screening colonoscopiesMichael Hjelkrem, Joel Stengel, Mark Liu, et al.
The American Journal of Gastroenterology|September 18, 2008
HCV in patients with end-stage renal diseaseEmuejevoke J Okoh, Jay R Bucci, James F Simon, et al.
Hepatology (Baltimore, Md.)|December 5, 2008
Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trialStephen A Harrison, Will Fecht, Elizabeth M Brunt, et al.
Therapeutic Advances in Gastroenterology|June 23, 2011
Prevalence of colonic adenomas in patients with nonalcoholic fatty liver diseaseNadege T Touzin, Kelvin N V Bush, Christopher D Williams, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2006
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver diseaseNicole A Palekar, Rhonda Naus, Steven P Larson, et al.
Hepatology (Baltimore, Md.)|July 9, 2016
Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic ChallengesGeorge Cholankeril, Ryan B Perumpail, Edward A Pham, et al.
Archives of Pathology & Laboratory Medicine|January 5, 2006
Diabetic hepatosclerosis: diabetic microangiopathy of the liverStephen A Harrison, Elizabeth M Brunt, Zachary D Goodman, et al.
Pageof 32

Showing results (101-110 of 318) with videos related to

Sort By:
Pageof 32
Nature Medicine|June 12, 2025
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Nature Medicine|March 9, 2023
Challenges and opportunities in NASH drug developmentStephen A Harrison, Alina M Allen, Julie Dubourg, et al.
Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2010
MiraLAX is not as effective as GoLytely in bowel cleansing before screening colonoscopiesMichael Hjelkrem, Joel Stengel, Mark Liu, et al.
The American Journal of Gastroenterology|September 18, 2008
HCV in patients with end-stage renal diseaseEmuejevoke J Okoh, Jay R Bucci, James F Simon, et al.
Hepatology (Baltimore, Md.)|December 5, 2008
Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trialStephen A Harrison, Will Fecht, Elizabeth M Brunt, et al.
Therapeutic Advances in Gastroenterology|June 23, 2011
Prevalence of colonic adenomas in patients with nonalcoholic fatty liver diseaseNadege T Touzin, Kelvin N V Bush, Christopher D Williams, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2006
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver diseaseNicole A Palekar, Rhonda Naus, Steven P Larson, et al.
Hepatology (Baltimore, Md.)|July 9, 2016
Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic ChallengesGeorge Cholankeril, Ryan B Perumpail, Edward A Pham, et al.
Archives of Pathology & Laboratory Medicine|January 5, 2006
Diabetic hepatosclerosis: diabetic microangiopathy of the liverStephen A Harrison, Elizabeth M Brunt, Zachary D Goodman, et al.
Pageof 32